NEW YORK (GenomeWeb) – N-of-One announced today that it has signed an agreement with molecular diagnostics company Admera Health to provide clinical interpretation for patients tested with Admera's OncoGxOne 64-gene oncology panel.
Already have a GenomeWeb or 360Dx account?Login Now.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.